Effect of carbidopa on the excretion of sodium, dopamine, and ouabain- like substance in the rat

Hypertension

Volumn 30, Issue 6, 1997, Pages 1544-1548

  Ho, Chung Shun ^a   Butt, Asif ^b   Semra, Yemane K ^b   Swaminathan, R ^b,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Carbidopa; Dopamine; Ouabain; Sodium; Sodium transport inhibitor, endogenous

Indexed keywords

CARBIDOPA; DIGITALIS LIKE FACTOR; DOPAMINE; SODIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOSE RESPONSE; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SALT INTAKE; SODIUM TRANSPORT; URINARY EXCRETION;

EID: 0343471084     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1544     Document Type: Article

References (27)

1. Lee MR. Dopamine and the kidney: ten years on. Clin Sci. 1993; 84:357-375.
2. Ho CS, Fung SL, Swaminathan R. The effect of salt loading on the urinary excretion of dopamine and sodium transport inhibitor in the rat. Clin Exp Hyperten. 1994;16:135-146.
3. Ball SG, Oates NS, Lee MR. Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med. 1978;55:167-173.
4. Alexander RW, Gill JR Jr, Yamabe H, Lovenberg W, Keiser HR. Effects of dietary sodium and of acute saline infusion on the inter-relationship between dopamine excretion and adrenergic activity in man. J Clin Invest. 1974;54:197-200.
5. Woolfson RG, Poston L, De Wardener HE. Digoxin-like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int. 1994;46:297-309.
6. Wauquier I, Devynck MA. Body fluid variations and endogenous digitalis-like compounds during chronic NaCl loading in Wistar rats. Clin & Exp Hypertens Theory Pract. 1989;A11:1217-1234.
7. Gruber KA, Whitaker JM, Buckalew VMJ. Endogenous digitalis-like substance in plasma of volume expanded dogs. Nature. 1480;287:743-745.
8. Hamlyn JM, Blaustein MP, Bova S, Ducharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acact Sci U S A. 1991;88:6259-6263.
9. Lewis LK, Yandle TG, Lewis JG, Richards AM, Pidgeon GB, Kaaja RJ, Nicholls MG. Ouabain is not detectable in human plasma. Hypertension. 1994;24:549-555.
10. Doris PA, Jenkins LA, Stocco DM. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension. 1994;23:632-638.
11. +)ATPase associated with essential hypertension. Nature. 1982;300:650-652.
12. Poston L, Sewell RB, Wilkinson SP, Richardson PJ, Williams R, Clarkson EM, MacGregor GA, de Wardener HE. Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J. 1981;282:847-849.
13. Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Esuchi C. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Comm. 1990;173:1093-1101.
14. 86Rb uptake by erythrocytes in extracts of human plasma. Clin Sci. 1989;77:375-381.
15. Harris DW, Clark MA, Fisher JF, Hamlyn JM, Kolbasa KP, Ludens JH. DuCharme DW. Development of an immunoassay for endogenous digitalis-like factor. Hypertension. 1991;17:936-943.
16. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci. 1976;19:935-947.
17. de Wardener HE, Clarkson EM. Concept of natriuretic hormone. Physiol Rev. 1985;65:658-759.
18. Blaustein M. Sodium ions, calcium ions, blood pressure regulation and hypertension: A reassessment and a hypothesis. Am J Physiol. 1977;232:C165-C173.
19. Harvey JN, Casson IF, Clayden AD, Cope GF, Perkins CM, Lee MR. A paradoxical fall in urine dopamine output when patients with essential hypertension are given added dietary salt. Clin Sci. 1984;67:83-88.
20. Shikuma R, Yoshimura M, Kambara S, Yamazaki H, Takashini R, Takahash H, Takeda K, Ijichi H. Dopaminergic modulation of salt sensitivity in patients with essential hypertension. Life Sci. 1986;38: 915-921.
21. Saito I, Takeshita E, Saruta TM, Nagano S, Sekihara T. Urinary dopamine excretion in normotensive subjects with or without family history of hypertension. J Hypertens. 1986;4:57-60.
22. Semra Y, Butt AN, Swaminathan R. Effect of salt intake on excretion of endogenous ouabain-like substance measured by RIA. Clin Chem. 1996;42:1949-1954.
23. Chan JCN, Critchley JAJH, Ho CS, Nicholls MG, Cockram CS, Swaminathan R. Atrial natriuretic peptide and urinary dopamine output in non-insulin dependent diabetes mellitus. Clin Sci. 1992; 83:247-253.
24. Weicker H, Ferandi M, Hagele H, Pluto R. Electrochemical detection of catecholamines in urine and plasma after separation with HPLC. Clin Chim Acta. 1984;141:17-25.
25. Wong SY, Ho CS, Panesar NS, Swaminathan R. The contribution of steroids to digoxin-like immunoreactivity in cord blood. Ann Clin Biochem. 1992;29:337-342.
26. Goto A, Yamada K, Yamada N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev. 1992:44:377-399.
27. Butt AN, Semra Y, Ho CS, Chan J, Cockram C, Swaminathan R. Serum ouabain concentration in non-insulin dependent diabetes mellitus (NIDDM). J Hum Hypertens. 1996;10:440.